Literature DB >> 12655423

Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia.

Matthias T F Wolf1, Eva Mildenberger2, Thomas Lennert1, Ioannis Anagnostopoulos3, Christina Zinn4, Karl Paul4, Rolf Keitzer4, Hans Versmold1.   

Abstract

UNLABELLED: We report the case of a 12-year-old boy, who developed Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disease (PTLD) 7 years after renal transplantation. He responded well to the reduced immunosuppressive therapy and treatment with ganciclovir. Two years later he developed severe pneumonia and hypogammaglobulinaemia related to EBV infection exacerbation. An X-ray film revealed persistent pneumonia in the right lung. Lung biopsy showed a large, diffuse EBV-associated B-cell lymphoma. This constellation suggested re-occurrence of the primary PTLD.
CONCLUSION: We present a case of recurring Epstein-Barr virus-associated post-transplant lymphoproliferative disease with a remarkably late onset in addition to hypogammaglobulinaemia.

Entities:  

Mesh:

Year:  2003        PMID: 12655423     DOI: 10.1007/s00431-002-1120-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma.

Authors:  L M Larratt; M Hamilton; R Coupland; J K Preiksaitis
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

2.  Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3.

Authors:  A Linde; R Söderström; C I Smith; M Sällberg; H Dahl; R Grubb; J Björkander; L Hammarström
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 3.  [Severe leukopenia and thrombocytopenia and transient acquired hypogammaglobulinemia in a patient with infectious mononucleosis].

Authors:  A Aloy Duch; J A Hernández Hernández; E Muñiz Díaz; M Hernández Regi; J M Llibre Codina; M González-Moreno Portugal
Journal:  Med Clin (Barc)       Date:  1992-02-22       Impact factor: 1.725

4.  Post-transplant lymphoproliferative disease in children.

Authors:  M H Collins; K T Montone; A M Leahey; R L Hodinka; K E Salhany; D L Kramer; C Deng; J E Tomaszewski
Journal:  Pediatr Transplant       Date:  2001-08

5.  Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.

Authors:  D Ellis; R Jaffe; M Green; J J Janosky; S Lombardozzi-Lane; R Shapiro; V Scantlebury; C Vivas; M L Jordan
Journal:  Transplantation       Date:  1999-10-15       Impact factor: 4.939

Review 6.  The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.

Authors:  M Green; J Reyes; S Webber; D Rowe
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

Review 7.  The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.

Authors:  M A Nalesnik
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

8.  Tacrolimus: the good, the bad, and the ugly.

Authors:  D H Chand; S M Southerland; R J Cunningham
Journal:  Pediatr Transplant       Date:  2001-02

Review 9.  The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.

Authors:  W S Hsieh; M V Lemas; R F Ambinder
Journal:  Transpl Infect Dis       Date:  1999-09       Impact factor: 2.228

10.  The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children.

Authors:  M Ho; R Jaffe; G Miller; M K Breinig; J S Dummer; L Makowka; R W Atchison; F Karrer; M A Nalesnik; T E Starzl
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.